A new survey shows many CEOs are expecting a robust economic surge, thanks to pro-business policies from the new ...

Hedge fund stock-pickers lost billions of dollars on Monday in a rout in global technology shares sparked by the emergence of ...

Swiss biopharma company BioVersys said on Wednesday it had launched an initial public offering on the SIX stock exchange priced at 36 Swiss francs ($39.84) per share.